Date:
March 2022

Issue:
269

File Type:
PDF

View the PDF

Includes: The PREVENT Study, Dr. Philip Barber bio, our first OPEN MIC NIGHT, PROpel Suggests Adding Olaparib to Abi-raterone Improves Outcomes, Risk vs. Benefit for Active Surveillance for Patients with Intermediate-Risk Disease, Epide-miology, Initial Diagnosis, and Life Expectancy of Men With Prostate Cancer, Facts and Recommendations on Early Detection of PC, Calgary to build cyclotron for radiopharmaceuticals, and more!

Leave a Reply

Your email address will not be published.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.